CHRU Besançon - Hôpital Minjoz
CHRU Besançon - Hôpital Minjoz
Besançon, France3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, marginal zone lymphoma, neoplasm | Recruiting | Phase 3 | 2026-06-15 | NCT06006117 | |
| Glofitamab in Real Life | large B-cell lymphoma | Recruiting | Not stated | 2026-06-03 | NCT06994169 | |
| French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T) | Hematopathology Eligible or CAR-t Cell Treatment | Recruiting | Not stated | 2026-03-04 | NCT04328298 |